Skip to content

Clinical trials

Neoplasm Metastasis trials in Croatia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: Croatia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20073
20082
20093
20101
20131
20142
20163
20172
20181
20191
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status4
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Puma Biotechnology, Inc.2
Acrotech Biopharma Inc.1
Cardiovascular and Interventional Radiological Society of Europe1
Croatian Cooperative Group for Clinical Research in Oncology1
Eli Lilly and Company1
Esperas Pharma Inc.1
G1 Therapeutics, Inc.1
Halozyme Therapeutics1
Institut de Recherches Internationales Servier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis23
Breast Neoplasms7
Colorectal Neoplasms3
Neoplasms3
Prostatic Neoplasms3
Adenocarcinoma2
Carcinoma, Non-Small-Cell Lung2
Colonic Neoplasms2
Recurrence2
Stomach Neoplasms2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.